Theranos is expanding what it started two years ago in the Phoenix market with a new Pennsylvania partnership and a recent FDA approval.
Mylan announced Thursday that it had launched its generic version of Valeant’s Targretin (bexarotene) 75-mg capsules.
The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics.
The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance.
Rite Aid's latest pharmacy initiative improves patient convenience and medication adherence.
The FDA has introduced a new website for Risk Evaluation and Mitigation Strategies, called REMS@FDA, to provide a standardized source of information about approved REMS.
DSN examines chain pharmacy, including in-depth coverage of technology, automation and generics, in this multi-page report.
Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement Monday criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.
Sens. Richard Blumenthal, D-Conn., and Sen. Dick Durbin, D-Ill., proposed three amendments to the National Defense Authorization Act that would impact how the military addresses supplementation.
The credibility of the vitamins, minerals and supplements business has been attacked in recent months.
Mylan announced on Tuesday that it had launched its generic version of Teva’s Seasonique birth control.
The 21st Century Cures legislation would foster drug development.
HBO's "Real Sports with Bryant Gumbel" takes a hard look at the sports-nutrition supplements men and women in the military are taking to remain combat ready.
DSN examines chain pharmacy — including in-depth coverage of retail clinics, generics, consolidations, kiosks and more — in this multi-page report.
Leading dietary supplement associations on Tuesday spoke to Congressional staffers regarding appropriate herbal supplement tests.
Cardinal Health Specialty Solutions will emphasize the importance of patient-reported outcomes in developing chronic disease care programs.
The FDA will review GDUFA in June.
Five states now allow for automatic substitution for Food and Drug Administration approved interchangeable biologic products.
The OIG issued a report finding that while FDA inspection of generic manufacturers is up, those inspections are not as thorough as they could be.
A new PhRMA report released Monday found that branded manufacturers invested $51.2 billion last year in R&D.
The National Minority Quality Forum on Tuesday honored PhRMA's John Castellani, for helping to increase diversity in clinical trials.
DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.
Generic Pharmaceutical Association branches out with the creation of the Biosimilars Council.
According to the Food and Drug Administration, heart failure is a common condition that affects close to 5.1 million people in the United States. The condition arises when the heart cannot pump enough blood to meet the body’s needs.
Supplement industry under continued fire with latest criticism of FDA oversight of BMPEA ingredient coming from Sen. Chuck Schumer, D-N.Y.